Platelet Rich Plasma (PRP) Market By Product Type (Pure Platelet Rich Plasma, Pure Platelet Rich Fibrin, Leukocyte-Platelet Rich Fibrin, Others), By Application (General Surgery, Neurosurgery, Cardiac Surgery, Orthopedic Surgery, Others), By End User (Hospitals, Ambulatory Surgical Centers (ASCs), Others), and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

The global platelet rich plasma (PRP) market size was valued at USD 492.3 million in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 14.2% from 2024 to 2030. Platelet Rich Plasma (PRP) Market is a permanent solution for various conditions such as ligament/tendon sprains, arthritis, and tears. Platelet-rich plasma (PRP) therapy is usually done by utilizing the body's natural healing process. In this therapy, a concentration of platelets is injected into the damaged tendons, joints, and ligaments to accelerate healing that anticipates tissue repair. The platelets are considered to be rich in growth and healing factors. The Platelet plasma (PRP) injections are used in the treatment of various conditions such as shoulder pain and instability, lumbar spine disc pain, knee sprains and instability, hamstring and hip strains, ankle sprains, knee, hip, and other joint osteoarthritis among others. The major variables that are considerably boosting the target market's growth are Some of the key determinants driving the platelet-rich plasma market globally are an increase in the number of orthopedic surgeries and sports injuries, an increase in the number of cosmetic surgeries, growing awareness about platelet rich plasma treatment in dental health, approval of new devices and the discovery of new application areas, rising geriatric population, and a surge in awareness among the global population. The significant volatility in the price of platelet-rich plasma therapy, on the other hand, as well as inadequate reimbursement policies, would stifle the platelet-rich plasma market's growth.

Platelet Rich Plasma Prp Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

14.2%

Largest Market

North America

Fastest Growing Market

Europe
Platelet Rich Plasma (PRP) Market Dynamics

Increase in the geriatric population along with increase in health issues are the key factors attributing the growth of Platelet rich plasma (PRP) market. The rising applications of platelet rich plasma (PRP) in various areas anticipated to fuel the growth of the market. The soaring use of PRP application in the cosmetic surgeries is boosting the growth of the market. The successful application of PRP in the orthopedic disorders such as Achilles tendinopathy, knee osteoarthritis, rotator cuff tears, and lateral epicondylitis has enhanced the growth of the Platelet rich plasma market. Growing incidence of sport injuries is adding scope for further growth in the market. However, the high risk of contamination owing to improper storage is hampering the growth of the market. The difficulty in quality control of test results is hindering the growth of the Platelet rich plasma market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Platelet Rich Plasma Prp Market Segmentation

By Product Type
  • Pure Platelet Rich Plasma
  • Pure Platelet Rich Fibrin
  • Leukocyte-Platelet Rich Fibrin
  • Others
By Application
  • General Surgery
  • Neurosurgery
  • Cardiac Surgery
  • Orthopedic Surgery
  • Others
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Frequently Asked Questions

The Platelet Rich Plasma size was valued at USD 492.3 million in 2023  

Abbott Laboratories (U.S),Siemens Healthcare Inc. (Germany), Thermo Fischer Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S), Biocept, Inc (U.S.)

North America is the fastest-growing region for platelet rich plasma market  

1.Executive Summary
2.Global Platelet Rich Plasma Prp Market Introduction 
2.1.Global Platelet Rich Plasma Prp Market  - Taxonomy
2.2.Global Platelet Rich Plasma Prp Market  - Definitions
2.2.1.Product Type 
2.2.2.Application
2.2.3.End Users
2.2.4.Region
3. Global Platelet Rich Plasma Prp Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Platelet Rich Plasma Prp Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Platelet Rich Plasma Prp Market  By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Pure Platelet Rich Plasma
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Pure Platelet Rich Fibrin
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Leukocyte-Platelet Rich Fibrin
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Others
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6. Global Platelet Rich Plasma Prp Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. General Surgery
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Neurosurgery
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Cardiac Surgery
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Orthopedic Surgery
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Others
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7. Global Platelet Rich Plasma Prp Market  By End Users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Ambulatory Surgical Centers
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Others
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8. Global Platelet Rich Plasma Prp Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9. North America Platelet Rich Plasma Prp Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Product Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Pure Platelet Rich Plasma
9.1.2.Pure Platelet Rich Fibrin
9.1.3.Leukocyte-Platelet Rich Fibrin
9.1.4.Others
9.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.General Surgery
9.2.2.Neurosurgery
9.2.3.Cardiac Surgery
9.2.4.Orthopedic Surgery
9.2.5.Others
9.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals
9.3.2.Ambulatory Surgical Centers
9.3.3.Others
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10. Europe Platelet Rich Plasma Prp Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Pure Platelet Rich Plasma
10.1.2.Pure Platelet Rich Fibrin
10.1.3.Leukocyte-Platelet Rich Fibrin
10.1.4.Others
10.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.General Surgery
10.2.2.Neurosurgery
10.2.3.Cardiac Surgery
10.2.4.Orthopedic Surgery
10.2.5.Others
10.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Ambulatory Surgical Centers
10.3.3.Others
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11. Asia Pacific (APAC) Platelet Rich Plasma Prp Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Pure Platelet Rich Plasma
11.1.2.Pure Platelet Rich Fibrin
11.1.3.Leukocyte-Platelet Rich Fibrin
11.1.4.Others
11.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.General Surgery
11.2.2.Neurosurgery
11.2.3.Cardiac Surgery
11.2.4.Orthopedic Surgery
11.2.5.Others
11.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Ambulatory Surgical Centers
11.3.3.Others
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12. Middle East and Africa (MEA) Platelet Rich Plasma Prp Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Pure Platelet Rich Plasma
12.1.2.Pure Platelet Rich Fibrin
12.1.3.Leukocyte-Platelet Rich Fibrin
12.1.4.Others
12.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.General Surgery
12.2.2.Neurosurgery
12.2.3.Cardiac Surgery
12.2.4.Orthopedic Surgery
12.2.5.Others
12.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Ambulatory Surgical Centers
12.3.3.Others
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13. Latin America Platelet Rich Plasma Prp Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Pure Platelet Rich Plasma
13.1.2.Pure Platelet Rich Fibrin
13.1.3.Leukocyte-Platelet Rich Fibrin
13.1.4.Others
13.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.General Surgery
13.2.2.Neurosurgery
13.2.3.Cardiac Surgery
13.2.4.Orthopedic Surgery
13.2.5.Others
13.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Ambulatory Surgical Centers
13.3.3.Others
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Hoffman-La Roche Ltd. (Switzerland)
14.2.2.Abbott Laboratories (U.S)
14.2.3.Siemens Healthcare Inc. (Germany)
14.2.4.Thermo Fischer Scientific, Inc. (U.S.)
14.2.5.Bio-Rad Laboratories, Inc. (U.S)
14.2.6.Biocept, Inc (U.S.)
14.2.7.Illumina, Inc., (U.S)
14.2.8.AstraZeneca plc, (U.K)
14.2.9.Epigenomics AG (Germany)
14.2.10.Quest Diagnostics Incorporated (U.S.)
14.2.11.Myriad Genetics, Inc.(U.S.
15. Research Methodology 
16. Appendix and Abbreviations 
  • Hoffman-La Roche Ltd. (Switzerland)
  • Abbott Laboratories (U.S)
  • Siemens Healthcare Inc. (Germany)
  • Thermo Fischer Scientific, Inc. (U.S.)
  • Bio-Rad Laboratories, Inc. (U.S)
  • Biocept, Inc (U.S.)
  • Illumina, Inc., (U.S)
  • AstraZeneca plc, (U.K)
  • Epigenomics AG (Germany)
  • Quest Diagnostics Incorporated (U.S.)
  • Myriad Genetics, Inc.(U.S.

Adjacent Markets